TransMedics Group, Inc.
-
Ticker
TMDX
-
Industry
--None-- More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Andover, Massachusetts
TransMedics is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. They developed the Organ Care System, or the OCS, to replace a decades-old standard of care that they believe is significantly limiting access to life-saving transplant therapy for hundreds of thousands of patients worldwide
…More. Their innovative OCS technology replicates many aspects of the organ’s natural living and functioning environment outside of the human body. As such, the OCS represents a paradigm shift that transforms organ preservation for transplantation from a static state to a dynamic environment that enables new capabilities, including organ optimization and assessment.
TransMedics Group, Inc.
Most Recent Responsibility Report
MOST RECENT
2023 ESG Data Update
Report Locked. TransMedics Group, Inc. has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived TransMedics Group, Inc. Sustainability Report, TransMedics Group, Inc. Corporate Social Responsibility Report, TransMedics Group, Inc. CSR Report, TransMedics Group, Inc. Corporate Responsibility, TransMedics Group, Inc. CR Report, TransMedics Group, Inc. Citizenship Report, TransMedics Group, Inc. ESG Report, and TransMedics Group, Inc. Environmental Report online.